Arkolith/Insider Trading/EDIT/Form 4

Mei Baisong

SVP, CHIEF MEDICAL OFFICEREditas Medicine, Inc. (EDIT) · full profile →Form 4 · filed Mar 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$191K
Net Open-Market Flow
-$191K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2024Sell(S)20K$9.42$191K142K
Mar 2, 2024Grant(A)51K—$0123K
Mar 2, 2024Grant(A)19K—$0162K
Mar 2, 2024Grant(A)19K—$0142K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2024Grant(A)153K—$0153K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001650664-24-000013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Editas Medicine, Inc.

Build

Ask your agent about EDIT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001650664-24-000013"
Ask your agent
Use Arkolith to summarize insider buying and selling at Editas Medicine, Inc.
over the last 90 days and cite the filings.